BioTelemetry (BEAT) Is Undervalued And Offers Investors Huge Upside Potential
October 09, 2015 at 07:01 AM EDT
Biotelemetry (BEAT) has technology that can monitor a variety of bodily functions including: pulse, heart rate, respiration and perspiration. They are in a growing sector, undervalued fundamentally and recently become profitable.